Design, synthesis, in silico prediction of ADMETox properties and antineoplastic evaluation of alpha-aryltetralones and alpha-fluoro-alpha-aryltetralones derivatives

Vol. 1, 2019 - 109249
Poster and Oral (selected)
Favorite this paper
How to cite this paper?
Abstract

Breast cancer is the most commonly occurring cancer in women. Leukemia was the sixth most common cause of cancer deaths.1 In addition, resistance to chemotherapy poses additional challenges to drug design. Flavonoid compounds display diverse biological activities such as antioxidant, anticancer and anti-inflammatory activities.2 The aim of this work was to design and synthesize carba-isoflavanone analogues, evaluate their in silico properties and antineoplastic activities. The synthesis was performed by palladium catalyzed α-arylation of α-tetralones and α-fluoro-tetralones with moderate to good yields up to 92%. Theoretical calculations predicted favorable physicochemical properties and low toxicity risks. The molecules were evaluated on cell lines with profiles of drug resistance, two breast cancers and three chronic myeloid leukemias, and compared to a non-tumor cell line. Results were promising for Lu45, Lu44, Lu48 and Lu47 (IC50= 36.37±2.05µM; 34.62±1.73µM; 29.50±1.51µM; 27.06±1.28µM, respectively) in FEPS cell line, a multidrug resistant leukemia cell.

Institutions
  • 1 UNIVERSIDADE DO ESTADO DO RIO DE JANEIRO
  • 2 Universidade Federal do Rio de Janeiro
Track
  • 2. Medicinal Chemistry of Synthetic Compounds
Keywords
drug design
anticancer agents
carba-isoflavonoids
Organic Synthesis
molecular ddescriptors